Lifecore Biomedical: Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that the company will participate at the 2025 BIO CEO & Investor Conference. The conference will take place February 10-11, 2025, in New York, NY.Details regarding Lifecore's participation are as follows:2025 BIO CEO ...Full story available on Benzinga.com